SCHEMBL10355104

SCHEMBL10355104

COC(=O)c1cc(I)c(N)c(I)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 4/20 0.52
▸ CA2 P00918 4/20 0.52
▸ CA12 O43570 3/20 0.52
▸ CA7 P43166 3/20 0.52
▸ CA9 Q16790 3/20 0.52
▸ CA14 Q9ULX7 3/20 0.52
▸ KDM4E B2RXH2 5/20 0.50
▸ GAA P10253 3/20 0.50
▸ POLB P06746 3/20 0.50
▸ XDH P47989 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ NFKB2 Q00653 1/20 0.50
▸ RELA Q04206 1/20 0.50
▸ FUT7 Q11130 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MAPT P10636 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2720327 0.90 KDM4E (0.51) CA1CA2CA12CA7CA9
SCHEMBL29473216 0.90 KDM4E (0.51) CA1CA2CA12CA7CA9
SCHEMBL18031415 0.89 KDM4E (0.58) CA1CA2CA12CA7CA9
SCHEMBL18301336 0.89 CA12 (0.46) CA1CA2CA12CA7CA9
SCHEMBL3709901 0.87 CA1 (0.44) CA1CA2CA12CA7CA9
SCHEMBL3717095 0.87 CA1 (0.44) CA1CA2CA12CA7CA9
SCHEMBL3652117 0.87 KDM4E (0.47) CA1CA2CA12CA7CA9
SCHEMBL15970899 0.87 KDM4E (0.46) CA1CA2CA12CA7CA9
SCHEMBL3431753 0.86 KDM4E (0.44) CA1CA2CA12CA7CA9
SCHEMBL15970661 0.83 XDH (0.45) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230532-B1 2-[(3,5-Dihalo-4-Aminobenzyl)] Imidazolines ABBOTT LABORATORIES (US) 1990-09-26 — — EP disclosed
EP-0230532-A1 2-[(3,5-Dihalo-4-Aminobenzyl)] Imidazolines ABBOTT LABORATORIES (US) 1987-08-05 — — EP disclosed
US-4665095-A Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion ABBOTT LABORATORIES (US) 1987-05-12 — — US disclosed
Send feedback